Type-2 cGMP-dependent protein kinase suppresses proliferation and carcinogenesis in the colon epithelium

Bianca N Islam1, Sarah K Sharman2, Yali Hou2

  • 1Department of Internal Medicine, Case Western Reserve University, Cleveland, OH, USA.

Carcinogenesis
|February 21, 2022
PubMed

Insights

Cyclic-guanosine monophosphate (cGMP) signaling suppresses colon cancer. Protein kinase G2 (PKG2) is key, acting within epithelial cells to control proliferation and prevent tumor formation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Cyclic-guanosine monophosphate (cGMP) signaling exhibits anti-tumor properties relevant to colon cancer prevention.
  • The precise mechanisms and downstream effectors of cGMP's tumor-suppressive actions in the colon are not fully understood.

Purpose of the Study:

  • To investigate the expression and function of cGMP-dependent protein kinases (PKG1 and PKG2) in human colon tissues and their role in colon carcinogenesis.
  • To determine if PKG2 acts as a tumor suppressor in the colon epithelium.

Main Methods:

  • Characterized PKG1 and PKG2 expression in normal and cancerous human colon tissues using immunohistochemistry.
  • Utilized Prkg2 knockout (KO) mice and azoxymethane/dextran sulfate-sodium (AOM/DSS) treatment to assess PKG2's role in vivo.
  • Established and analyzed colon organoids from wild-type (WT) and Prkg2 KO mice to study epithelial cell proliferation and differentiation.

Main Results:

  • PKG1 localized to the stroma and lamina propria, while PKG2 was specifically found in the colon epithelium, with significantly decreased expression in tumors.
  • Prkg2 KO mice exhibited increased susceptibility to AOM/DSS-induced tumors, characterized by crypt hyperplasia and a higher polyp burden compared to WT mice.
  • Colon organoids from Prkg2 KO mice showed enhanced proliferation and impaired differentiation compared to WT controls, confirming PKG2's epithelial-cell intrinsic function.

Conclusions:

  • PKG2 is the primary mediator of cGMP's anti-carcinogenic effects in the colon epithelium.
  • PKG2 suppresses colon carcinogenesis by intrinsically regulating epithelial cell proliferation and differentiation.
  • Targeting PKG2 may offer a novel strategy for colon cancer prevention and therapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.4K